diabetes glp-1 vs sglt2 Receptor Agonists and Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs For older adults with diabetes,

Its also used in joint health supplements due to its potential anti-inflammatory properties, helping to protect cartilage in conditions like osteoarthritis

On the other hand, phentermine is more affordable and generally well-tolerated but carries a risk of cardiovascular side effects and is not recommended for those unable to tolerate stimulants

Alsabbagh et al

Where the evidence is actually strongest (and why it matters for Meto readers) For a weight-loss / metabolic audience, the most evidence-backed stacking conversation in 2026 is not peptides + peptides. Its: GLP-1based therapy + a muscle-preservation strategy (training + protein + potentially adjunct pharmacology in select contexts) Semaglutides pivotal obesity trial publication notes DXA substudies showing a larger reduction in fat mass than lean mass